AGBA shares surge 28% as $4bn merger with Triller nears completion
AGBA Group Holding Limited (NASDAQ: AGBA) saw a significant 28% rise in its stock price, riding on the anticipation of its upcoming merger with Triller ... Read More
Biotech stocks in trouble? Immatics shares plunge after $150m funding news shocks investors
Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company focused on cancer immunotherapies, has seen its shares decline significantly after announcing a $150 million public offering. ... Read More
Immuron Limited reveals key findings from NMRC study, eyes future collaboration with U.S. DoD
Immuron Limited has announced the results of a Campylobacter human infection model study conducted by the U.S. Naval Medical Research Command (NMRC). The Melbourne-based biopharmaceutical ... Read More
Banzai International’s stock skyrockets 96% after massive debt restructuring
Banzai International experienced a dramatic 96% surge in its stock value, hitting $8.23 after announcing a substantial debt restructuring plan worth $24.8 million. This comes ... Read More
SAP completes $1.5bn WalkMe acquisition, enhancing digital adoption capabilities
SAP SE (NYSE: SAP) announced the successful completion of its acquisition of WalkMe Ltd., a company renowned for its digital adoption platform (DAP) technology. WalkMe ... Read More
Achilles Therapeutics shares skyrocket 32% after massive cost cuts—Is this the turnaround it needs?
Achilles Therapeutics PLC saw its American Depositary Receipts (ADRs) soar by an impressive 32%, reflecting renewed investor optimism following the company’s recent announcement of stringent ... Read More
Cibus stock crashes as investors panic over sudden public offering move
Cibus Inc., an agricultural biotechnology company specialising in gene editing, saw its shares tumble after announcing an underwritten public offering of its Class A common ... Read More
Netcapital shares plunge on 91% revenue decline in first quarter 2025
Shares of Netcapital Inc., a digital private capital markets ecosystem, nosedived after the company reported a dramatic 91% fall in revenue for the first quarter ... Read More
Exicure’s stock explodes 78% overnight – but is the comeback for real?
Shares of biopharmaceutical company Exicure Inc. skyrocketed by 78% in after-hours trading, closing at $2.84. The surge came after Exicure announced a significant debt-for-equity exchange ... Read More
Centessa Pharmaceuticals pulls off massive $225m deal—Stock price jumps
Centessa Pharmaceuticals has experienced a substantial rise in its share price after completing an upsized public offering of American Depositary Shares (ADSs). The company, listed ... Read More